BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright ©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 108585
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108585
Table 1 Representative positron-emitting radionuclides used in immuno-positron emission tomography for hematologic malignancies
Radionuclide
Emission
Half-life
β+ ray emitting rate
Copper-64 (64Cu)β+, β-, EC12.7 h19%
Zirconium-89 (89Zr)β+, EC78.4 h23%
Gallium-68 (68Ga)β+, EC68 min89%
Table 2 Surface antigens targeted in immuno-positron emission tomography for hematologic malignancies
Types of hematologic malignancy
Surface antigens targeted in immuno-PET detection
Non-Hodgkin lymphomaCD19, CD20, CXCR4
Hodgkin lymphomaCD30
Multiple myelomaCD38, CD138, VLA-4, BCMA, SLAMF7, CXCR4
Acute myeloid leukemiaCD33, CXCR4
Acute lymphoblastic leukemiaCXCR4